Base de données de recherche subventionnée canadienne sur la COVID-19

Université du Québec à Chicoutimi

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 61 through 70 of 166 results (Download Results)

Show results per page

COVID-19 Variant Supplement – Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2

Leclerc, Denis | CHU de Québec | Operating Grant | $50,000

CIHR Quebec 2021

Role of antibodies in platelet response to SARS-CoV-2 and its variants

Boilard, Eric | Université Laval | Operating Grant | $261,700

CIHR Quebec 2021

Addressing socioeconomic and racial/ethnic inequities in COVID‑19 vaccine hesitancy among parents and adolescents

Zinszer, Kate A | Université de Montréal | Operating Grant | $478,685

CIHR Quebec 2021

Immunogénicité d’un vaccin mucosal contre le SARS-CoV2 responsable de la covid-19

Fortier, Isabelle | Cégep de Lévis-Lauzon | Other | $75,000

CIHR Quebec 2020

The Impact of the COVID‑19 pandemic on youth substance use problems and services: Knowledge synthesis with Indigenous Nations and organizations

Wendt, Dennis C | McGill University | Other | $100,000

CIHR Quebec 2021

Coping strategies and mental health: quantitative and qualitative insight into the COVID‑19 experience in young adults

Sylvestre, Marie-Pierre | Centre hospitalier de l'Université de Montréal | Project Grant | $457,422

CIHR Quebec 2021

Investigating the Post-Acute Sequelae of SARS-CoV-2 Infections: a Patient Oriented Canadian COVID‑19 Emergency Department Rapid Response Network (CCEDRRN) Study

Archambault, Patrick | Université Laval | Operating Grant | $499,945

CIHR Quebec 2021

COVID-19 Variant Supplement – Understand the high pathogenicity and zoonotic transmission of the COVID‑19 virus: evasion of host innate immune responses

Liang, Chen | Lady Davis Institute for Medical Research | Operating Grant | $50,000

CIHR Quebec 2021

Transdiagnostic internet cognitive-behavior therapy for mixed anxiety and depressive disorders in primary care: A dissemination and implementation study

Roberge, Pasquale | Université de Sherbrooke | Operating Grant | $200,000

CIHR Quebec 2020

COVID-19 Variant Supplement – Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.

Moitessier, Nicolas R | McGill University | Operating Grant | $50,000

CIHR Quebec 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2

Role of antibodies in platelet response to SARS-CoV-2 and its variants

Addressing socioeconomic and racial/ethnic inequities in COVID‑19 vaccine hesitancy among parents and adolescents

Immunogénicité d’un vaccin mucosal contre le SARS-CoV2 responsable de la covid-19

The Impact of the COVID‑19 pandemic on youth substance use problems and services: Knowledge synthesis with Indigenous Nations and organizations

Coping strategies and mental health: quantitative and qualitative insight into the COVID‑19 experience in young adults

Investigating the Post-Acute Sequelae of SARS-CoV-2 Infections: a Patient Oriented Canadian COVID‑19 Emergency Department Rapid Response Network (CCEDRRN) Study

COVID-19 Variant Supplement – Understand the high pathogenicity and zoonotic transmission of the COVID‑19 virus: evasion of host innate immune responses

Transdiagnostic internet cognitive-behavior therapy for mixed anxiety and depressive disorders in primary care: A dissemination and implementation study

COVID-19 Variant Supplement – Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.